Franklin Biotechnology Discovery Fund Class R6 (FRBRX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
178.76
-0.52 (-0.29%)
At close: Mar 6, 2026
FRBRX Holdings Information
FRBRX is a mutual fund with a total of 92 individual holdings. The top holdings are Gilead Sciences stock at 6.17%, Amgen at 4.81%, Vertex Pharmaceuticals at 4.71%, Jazz Pharmaceuticals at 4.56%, and Regeneron Pharmaceuticals at 4.44%.
Total Holdings
92
Top 10 Percentage
40.30%
Asset Class
Equity
Fund Category
Health
Assets
1.04B
Forward PE Ratio
16.80
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 6.17% |
| 2 | AMGN | Amgen Inc. | 4.81% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 4.71% |
| 4 | JAZZ | Jazz Pharmaceuticals plc | 4.56% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 4.44% |
| 6 | ARGX | argenx SE | 4.03% |
| 7 | PRAX | Praxis Precision Medicines, Inc. | 3.02% |
| 8 | INSM | Insmed Incorporated | 2.90% |
| 9 | ASND | Ascendis Pharma A/S | 2.88% |
| 10 | GH | Guardant Health, Inc. | 2.78% |
| 11 | PTCT | PTC Therapeutics, Inc. | 2.74% |
| 12 | TERN | Terns Pharmaceuticals, Inc. | 2.61% |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.22% |
| 14 | MIRM | Mirum Pharmaceuticals, Inc. | 2.18% |
| 15 | GPCR | Structure Therapeutics Inc. | 1.97% |
| 16 | RVMD | Revolution Medicines, Inc. | 1.92% |
| 17 | MLYS | Mineralys Therapeutics, Inc. | 1.89% |
| 18 | AZN | AstraZeneca PLC | 1.86% |
| 19 | NBIX | Neurocrine Biosciences, Inc. | 1.80% |
| 20 | ABVX | ABIVAX Société Anonyme | 1.79% |
| 21 | EYPT | EyePoint, Inc. | 1.68% |
| 22 | IONS | Ionis Pharmaceuticals, Inc. | 1.66% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 1.57% |
| 24 | CNTA | Centessa Pharmaceuticals plc | 1.48% |
| 25 | LLY | Eli Lilly and Company | 1.43% |
As of Jan 31, 2026